News

Wednesday 30th August 2023

MELODY: Study finds immunosuppressed people make antibodies after COVID-19 vaccination

People with weakened immune systems, including those with Scleroderma, are at increased risk of developing a severe infection after being exposed to Covid-19. Vaccinations and booster doses have been offered to immunosuppressed patients since the roll-out of the NHS vaccination programme in 2020. But how well do they work in people who have weakened immune systems? Read on to hear the exciting findings from the MELODY study!

Read Article

Thursday 26th August 2021

Just in time! UK approves new COVID-19 treatment for immunocompromised individuals

As OCTAVE study sheds light on the reduced immune response in those with chronic illness, the new antibody treatment from Regeneron and Roche could be of great benefit for those who are immunosuppressed or immunocompromised.

Read Article

Friday 6th August 2021

Utilizing Ultrasound

Dr Victoria Flower was awarded funding by SRUK to research non-invasive methods of skin assessment in scleroderma. Last month, her work was published in The Journal of Rheumatology, discussing the potential use of High Frequency Ultrasound as a more objective and detailed measure of skin involvement in scleroderma.

Read Article

Friday 21st August 2020

Findings of nintedanib's safety and tolerability published

A team of researchers based in the USA, UK, Germany, Switzerland and Japan sought to examine the results of the SENSCIS trial to assess the safety and tolerability of nintedanib in people with SSc-ILD.

Read Article

Friday 30th August 2019

The future of systemic sclerosis classification

A recent review published in Nature Rheumatology focused on research into the classification of scleroderma, which suggests that the current classification does not capture the heterogeneity of the condition.

Read Article

Thursday 22nd August 2019

Understanding vascular involvement in systemic sclerosis

In her talk at SRUK’s regional conference in Cambridge, Dr Robyn Domsic discussed a variety of topics that are crucial to understanding vascular involvement and expert recommendations on management.

Read Article

Tuesday 20th August 2019

Oral and dental involvement in scleroderma: What happens and how can it be managed?

Recently, a poll was run online to understand what oral and dental complications of scleroderma impact those living with the condition the most. We’ve selected some questions from the poll to answer here.

Read Article

Friday 24th August 2018

Remembering ‘CREST’: useful acronym or dangerous diagnostic hinderance?

Slightly older ears may remember the days of ‘CREST’, the now outdated term for Scleroderma. But what did ‘CREST’ mean? Why was it used? And why was the term abandoned in mainstream medical practice?

Read Article

Monday 20th August 2018

Why does Raynaud’s Phenomenon affect more women? Estrogen could be the answer

It’s been well established that women are more likely to be affected by Raynaud’s phenomenon than men but why? Let's look into the reasons behind this.

Read Article

Thursday 24th August 2017

New blood test may diagnose scleroderma

A new blood test has been developed that it is hoped will be used to diagnose scleroderma in the future.

Read Article